LEP rs7799039: Understanding the Leptin Promoter Variant
The rs7799039 variant is a single nucleotide polymorphism located in the promoter region of the LEP gene. It is frequently studied for its potential associations with circulating leptin levels, satiety regulation, and susceptibility to metabolic conditions like obesity and insulin resistance.
What each genotype means
Typical leptin promoter profile
This genotype represents the major allele configuration for the LEP promoter region. Research into this variant has yielded inconsistent results regarding its influence on metabolic health, with some studies suggesting it may be associated with different circulating leptin levels compared to the A allele. Because findings are often mixed or population-specific, this genotype should not be used to predict individual health outcomes.
This is a common genotype found across most major continental ancestry groups.
Heterozygous leptin promoter variant
Carrying one copy of the A allele means you have a mix of the two common promoter configurations. Some research suggests that the A allele may be linked to variations in insulin resistance or metabolic markers, but these associations are frequently debated and vary significantly between different ethnic populations. There is no consensus on how this specific combination impacts individual physiology.
This heterozygous genotype is frequently observed in diverse populations worldwide.
Variant leptin promoter profile
The AA genotype has been studied for potential associations with elevated serum leptin levels, insulin resistance, and metabolic syndrome markers. However, scientific evidence is inconsistent, with some studies showing conflicting results depending on the ancestry of the population studied. It is important to note that these associations are statistical in nature and do not indicate a direct cause of any health condition.
This genotype is common, appearing in a significant portion of the population across major ancestry groups.
What is the rs7799039 Variant?
The rs7799039 variant, often referred to as the -2548G>A polymorphism, is a specific change in the DNA sequence located within the promoter region of the LEP gene. A promoter is a segment of DNA that acts as a control switch, determining how much of a gene's product is created. Because this variant sits in a regulatory area rather than the protein-coding sequence itself, researchers hypothesize that it may influence the expression levels of the leptin hormone. Located on chromosome 7, this SNP has been the subject of extensive investigation in the context of human metabolism. While it is a common genetic variation, its functional impact on the body remains a topic of ongoing scientific debate, as results from various studies have often been inconsistent across different populations and clinical settings.
The Role of the LEP Gene
The LEP gene provides the biological instructions for producing leptin, a hormone primarily secreted by adipose (fat) tissue. Leptin plays a critical role in energy balance by signaling to the brain—specifically the hypothalamus—to regulate appetite and energy expenditure. Under normal conditions, leptin helps the body maintain a stable weight by promoting satiety and increasing metabolic rate. However, in states of obesity, individuals often exhibit high levels of circulating leptin, a condition known as hyperleptinemia. Over time, this can lead to leptin resistance, where the brain stops responding effectively to the hormone's signals. Because leptin is central to how the body manages fat stores, variations in the LEP gene, such as rs7799039, are frequently examined to see if they contribute to differences in how individuals process energy and maintain body weight.
Research and Evidence Strength
The evidence linking rs7799039 to health outcomes is considered limited and mixed. Numerous studies have explored whether the A allele or the G allele correlates with obesity, insulin resistance, or weight gain, particularly in response to certain medications like antipsychotics. Some meta-analyses have suggested that the A allele might be associated with altered leptin levels or an increased risk of insulin resistance, but these findings are not universal. For instance, some research indicates that the A allele might act as a risk factor in certain populations while appearing protective in others. Furthermore, large-scale studies have often failed to find a consistent, major effect on body mass index (BMI) or weight change. Because of these conflicting results, the scientific community generally views this variant as a candidate for further study rather than a definitive predictor of metabolic health.
Population Frequency
The rs7799039 variant is highly common across diverse human populations. Data from genomic databases indicate that the minor allele frequency (MAF) typically ranges between 0.40 and 0.50 across major continental ancestry groups. This high frequency means that a large portion of the global population carries at least one copy of the A allele, and many individuals are homozygous for either the G or A allele. Because the variant is so prevalent, it is considered a common polymorphism rather than a rare mutation. This widespread distribution is one reason why researchers have been able to conduct so many association studies, though it also highlights the complexity of determining whether such a common variant has a meaningful impact on individual health outcomes.
Interpreting Your Genetic Information
It is important to understand that genetic variants like rs7799039 do not act in isolation. Metabolic health is influenced by a complex interplay of thousands of genetic markers, environmental factors, diet, physical activity, and lifestyle choices. Having a specific genotype for this SNP does not diagnose a condition or guarantee a specific health outcome. If you are concerned about your weight, metabolic health, or how your body responds to medications, it is essential to consult with a qualified healthcare provider or a registered dietitian. They can provide personalized guidance based on your clinical history and current health status. Never use information about a single genetic variant to make decisions about your medical care or to alter prescribed treatments without professional medical supervision.
How common is this variant?
The rs7799039 variant is common, with a minor allele frequency of approximately 0.40–0.50 across major continental ancestry groups.
Frequently asked questions
Does the rs7799039 variant cause obesity?
No, this variant does not cause obesity. While some studies have investigated its association with body weight, obesity is a complex condition influenced by many genetic, environmental, and lifestyle factors.
Can I use this SNP to predict my leptin levels?
Current research is inconsistent regarding the impact of this SNP on leptin levels. It is not a reliable tool for predicting individual hormone levels or metabolic health.
Should I change my diet based on my rs7799039 genotype?
No. You should not change your diet based on a single genetic variant. Always consult with a healthcare professional or a registered dietitian for personalized nutritional advice.
Is this variant related to medication side effects?
Some studies have explored whether this variant influences weight gain associated with certain medications, but results have been mixed and inconclusive. Discuss any concerns about medication side effects with your prescribing physician.
Sources & further reading
Educational information only, last refreshed 9/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7799039?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29